Results 91 to 100 of about 11,471 (211)

Toxic Epidermal Necrolysis-like Cutaneous Lupus Erythematosus: A Series of Three Patients

open access: yes, 2010
Toxic epidermal necrolysis-like lesions have been described in the setting of lupus erythematosus, and have been considered as a specific hyperacute variant of cutaneous lupus erythematosus, with features different from classical drug-related toxic ...
VALENTE, Neusa Y. S.   +11 more
core   +1 more source

Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real‐World Analysis of WHO Pharmacovigilance Data

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 274-285, July 2026.
BRAF inhibitors and MEK inhibitors (MEKi) have reshaped the treatment of BRAFV600‐mutant malignancies; however, cutaneous adverse drug reactions (ADRs) remain a frequent and clinically impactful toxicity. Although clinical trials provide insight into their safety profiles, real‐world data on dermatologic ADRs are limited.
Natalia Sauer   +3 more
wiley   +1 more source

Pediatric SJS-TEN: Where are we now? [version 1; peer review: 2 approved]

open access: yesF1000Research, 2020
Stevens–Johnson syndrome and toxic epidermal necrolysis are rare severe blistering skin reactions triggered by medications or infections. Over the last 5 to 10 years, a number of important publications have advanced understanding of these diseases and ...
Michele Ramien, Jennifer L. Goldman
doaj   +1 more source

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1137-1161, July 2026.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda   +31 more
wiley   +1 more source

Toxic epidermal necrolysis caused by flurazepam?

open access: yes, 2005
Stevens-Johnson syndrome and toxic epidermal necrolysis are rare, but severe cutaneous reactions. Beside cutaneous manifestations, the syndrome is characterised by constitutional sypmtoms with even lethal consequences.
Bilusić, Marijo   +2 more
core  

Clinical Images: Skin manifestations and radiographic findings of anti‐SAE1 positive dermatomyositis

open access: yes
ACR Open Rheumatology, Volume 8, Issue 7, July 2026.
Amara Seng   +4 more
wiley   +1 more source

Utilization of Suprathel® in delayed surgical management of toxic epidermal necrolysis (TEN): A case report

open access: yesBurns Open
Given the lack of established practice guidelines for the management of cutaneous symptoms associated with toxic epidermal necrolysis, treatments range from various dressings to skin substitutes.
Isabella Lipkin   +2 more
doaj   +1 more source

A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis

open access: yesAnnals of Saudi Medicine, 2012
Toxic epidermal necrolysis represents an immunologic reaction to a foreign antigen and is most often caused by drugs. Atorvastatin, a blood cholesterol–lowering agent, is a recognized cause of rhabdomyolysis; while naproxen, a widely used nonsteroidal ...
Sheik Oaleed Noordally   +5 more
doaj   +1 more source

Progression of Toxic Epidermal Necrolysis After Tanning Bed Exposure

open access: yes, 2011
Background: In addition to recreational tanning bed use, UV radiation exposures are sometimes sought to self-treat skin conditions. The ability of tanning bed radiation exposure to trigger toxic epidermal necrolysis has not been reported.
Gatson, Na Tosha   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy